Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of celecoxib 400 mg capsules versus Celebrex 400 mg capsules in healthy Thai volunteers under fasting conditions
TCTR20210722002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib (2 arms), sponsored by Bio-innova. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
celecoxib
Beyond the preview
Go deeper on TCTR20210722002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210722002.